Do Price Subsidies on Artemisinin Combination Therapy for Malaria Increase Household Use?: Evidence from a Repeated Cross-Sectio
Peptide Cross-Linked Poly(2-oxazoline) as a Sensor Material for the Detection of Proteases with a Quartz Crystal Microbalance | Biomacromolecules
![PDF) Inflammatory bowel disease patients prioritize mucosal healing, symptom control, and pain when choosing therapies: Results of a prospective cross-sectional willingness-to-pay study PDF) Inflammatory bowel disease patients prioritize mucosal healing, symptom control, and pain when choosing therapies: Results of a prospective cross-sectional willingness-to-pay study](https://i1.rgstatic.net/publication/324391874_Inflammatory_bowel_disease_patients_prioritize_mucosal_healing_symptom_control_and_pain_when_choosing_therapies_Results_of_a_prospective_cross-sectional_willingness-to-pay_study/links/5accbd9ea6fdcc8bfc8809b0/largepreview.png)
PDF) Inflammatory bowel disease patients prioritize mucosal healing, symptom control, and pain when choosing therapies: Results of a prospective cross-sectional willingness-to-pay study
![Pharmaceuticals | Free Full-Text | Sweetening Pharmaceutical Radiochemistry by 18F-Fluoroglycosylation: Recent Progress and Future Prospects Pharmaceuticals | Free Full-Text | Sweetening Pharmaceutical Radiochemistry by 18F-Fluoroglycosylation: Recent Progress and Future Prospects](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-01175/article_deploy/html/images/pharmaceuticals-14-01175-sch002.png)
Pharmaceuticals | Free Full-Text | Sweetening Pharmaceutical Radiochemistry by 18F-Fluoroglycosylation: Recent Progress and Future Prospects
![Letters in Support of the Right to Try Clarification Act and an Inter-agency Taskforce on Psychedelic Medicines and Therapies - Chacruna Letters in Support of the Right to Try Clarification Act and an Inter-agency Taskforce on Psychedelic Medicines and Therapies - Chacruna](https://chacruna.net/wp-content/uploads/2022/08/Right-to-Try-WEB.jpg)
Letters in Support of the Right to Try Clarification Act and an Inter-agency Taskforce on Psychedelic Medicines and Therapies - Chacruna
A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells | ACS Medicinal Chemistry Letters
Piloting the Global Subsidy: The Impact of Subsidized Artemisinin-Based Combination Therapies Distributed through Private Drug S
![Optimum population-level use of artemisinin combination therapies: a modelling study - The Lancet Global Health Optimum population-level use of artemisinin combination therapies: a modelling study - The Lancet Global Health](https://www.thelancet.com/cms/attachment/2051280315/2059282037/gr1.jpg)